SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (816)1/8/1998 11:29:00 AM
From: Henry Volquardsen  Read Replies (1) of 1115
 
however the speculation is that BMY is in biz to make money for them not for LDAKA and the margin may not have been exciting enough for them

hmmmm! If the margin's are not that exciting for BMY could that be an indication that Lidakol may not be a prescription drug but may go over the counter instead? We speculated on that last year in regards to Lidakol being non mutagenic. Just speculating here but that could be very interesting. What if Lidak licenses to someone with more of a consumer products focus?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News